Minerva Neurosciences (NERV) Stock Statistics & Valuation Metrics

Minerva Neurosciences has a market cap or net worth of $242.34M. The enterprise value is $21.82M.

Minerva Neurosciences has 43,274,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Minerva Neurosciences’s return on equity (ROE) is 2.08 and return on invested capital (ROIC) is -15.79%.

The current PE Ratio of Minerva Neurosciences is ―. Minerva Neurosciences’s PEG ratio is <0.00001.

In the last 12 months, Minerva Neurosciences had revenue of 0.00 and earned -293.42M in profits. Earnings per share was -34.67.

In the last 12 months, operating cash flow was -9.44M and capital expenditures 0.00, giving a free cash flow of -9.44M billion.

Minerva Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Minerva Neurosciences upcoming earnings date is May 6, 2026, TBA (Confirmed).

Minerva Neurosciences as a current ratio of 36.29, with Debt / Equity ratio of -47.84%

In the past 12 months, Minerva Neurosciences has paid 0.00 in taxes.

Minerva Neurosciences EV to EBITDA ratio is -1.10, with an EV/FCF ratio of >-0.01.

Minerva Neurosciences has $82.30M in cash and marketable securities with $64.96M in debt, giving a net cash position of $17.34M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Minerva Neurosciences is $7.00, which is 11.43% higher than the current price. The consensus rating is Hold